Airway Management and Weight in Children
Study Details
Study Description
Brief Summary
The investigators in this study want to see how overweight/obese children who undergo elective surgery requiring airway management react to general anesthesia. They believe that the incidence of perioperative respiratory adverse events (PRAE) associated with Laryngeal mask airway (LMA) use during general anesthesia in overweight/obese children is lower than that associated with endotracheal intubation (ETT).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Endotracheal intubation
|
Device: Endotracheal intubation
COMPLETE
|
Experimental: Laryngeal mask airway
|
Device: Laryngeal mask airway
COMPLETE
|
Outcome Measures
Primary Outcome Measures
- Severe respiratory adverse events [perioperative period]
laryngospasm, bronchospasm
Eligibility Criteria
Criteria
Inclusion Criteria:
-
sex-specific body mass index (BMI) is ≥85th percentile
-
elective surgical outpatient peripheral or lower abdominal procedures
-
Surgery length estimated to last between 30 and 120 minutes
Exclusion Criteria:
-
Active gastro-esophageal reflux, possible difficult intubation or planned asleep fiber optic intubation, cardiac disease, thoracic deformities, upper abdominal, and thoracic or airway surgeries.
-
Children with active asthmatic attack or those considered to be "full stomach" will also be excluded.
-
Laparoscopic surgical procedures and those requiring extreme head-down tilt will also be excluded.
-
Children with a physiology or other condition requiring a certain type of airway for the procedure will also be excluded
-
Children whose anesthesiologist is not agreeable to randomization of airway management choice will also be excluded.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The University of Michigan | Ann Arbor | Michigan | United States | 48109 |
Sponsors and Collaborators
- University of Michigan
Investigators
- Principal Investigator: Olubukola Nafiu, MD, University of Michigan
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HUM00132290